Equity Method Investments - Summary of Balance Sheet and Income Statement Data for Equity Method Investments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Schedule of Equity Method Investments [Line Items]
Total revenue	$ 556	$ 481	$ 503
Total operating expenses	324	312	288
Operating income	232	169	215
Net income	568	556	546
Balance Sheets
Current assets	465	394
Total assets	2,318	2,347
Current liabilities	489	82
Non-current liabilities	2,322	2,723
Equity (Deficit)	(493)	(458)	(749)	$ (257)
Total liabilities and deficit	2,318	2,347
Mattox
Schedule of Equity Method Investments [Line Items]
Total revenue		66
Total operating expenses		9
Operating income		57
Net income		57
Balance Sheets
Current assets	11	13
Non-current assets	195	204
Total assets	206	217
Current liabilities	0	0
Non-current liabilities	9	12
Equity (Deficit)	197	205
Total liabilities and deficit	206	217
Mattox | Equity Method Investment, Nonconsolidated Investee, Other
Schedule of Equity Method Investments [Line Items]
Total revenue	88
Total operating expenses	12
Operating income	76
Net income	76
Amberjack
Schedule of Equity Method Investments [Line Items]
Total revenue		280	315
Total operating expenses		78	73
Operating income		202	242
Net income		201	243
Balance Sheets
Current assets	53	44	56
Non-current assets	786	836	804
Total assets	839	880	860
Current liabilities	5	10	4
Non-current liabilities	134	124	32
Equity (Deficit)	700	746	824
Total liabilities and deficit	839	880	860
Amberjack | Equity Method Investment, Nonconsolidated Investee, Other
Schedule of Equity Method Investments [Line Items]
Total revenue	271
Total operating expenses	66
Operating income	205
Net income	203
Mars
Schedule of Equity Method Investments [Line Items]
Total revenue		259	282
Total operating expenses		97	104
Operating income		162	178
Net income		163	179
Balance Sheets
Current assets	50	47	57
Non-current assets	245	269	173
Total assets	295	316	230
Current liabilities	26	23	8
Non-current liabilities	79	103	22
Equity (Deficit)	190	190	200
Total liabilities and deficit	295	316	230
Mars | Equity Method Investment, Nonconsolidated Investee, Other
Schedule of Equity Method Investments [Line Items]
Total revenue	211
Total operating expenses	91
Operating income	120
Net income	120
Bengal
Schedule of Equity Method Investments [Line Items]
Total revenue		65	77
Total operating expenses		30	30
Operating income		35	47
Net income		35	47
Balance Sheets
Current assets	28	33	35
Non-current assets	164	161	157
Total assets	192	194	192
Current liabilities	11	7	6
Non-current liabilities	0	0	0
Equity (Deficit)	181	187	186
Total liabilities and deficit	192	194	192
Bengal | Equity Method Investment, Nonconsolidated Investee, Other
Schedule of Equity Method Investments [Line Items]
Total revenue	46
Total operating expenses	29
Operating income	17
Net income	17
Explorer
Schedule of Equity Method Investments [Line Items]
Total revenue		329	258
Total operating expenses		175	115
Operating income		154	143
Net income		119	111
Balance Sheets
Current assets	85	74	93
Non-current assets	574	537	530
Total assets	659	611	623
Current liabilities	54	49	44
Non-current liabilities	508	459	442
Equity (Deficit)	97	103	137
Total liabilities and deficit	659	611	623
Explorer | Equity Method Investment, Nonconsolidated Investee, Other
Schedule of Equity Method Investments [Line Items]
Total revenue	405
Total operating expenses	178
Operating income	227
Net income	165
Colonial
Schedule of Equity Method Investments [Line Items]
Total revenue		1,395	829
Total operating expenses		660	449
Operating income		735	380
Net income		473	255
Balance Sheets
Current assets	695	501	323
Non-current assets	3,008	3,105	2,920
Total assets	3,703	3,606	3,243
Current liabilities	307	245	519
Non-current liabilities	3,503	3,508	2,873
Equity (Deficit)	(107)	(147)	(149)
Total liabilities and deficit	3,703	3,606	3,243
Colonial | Equity Method Investment, Nonconsolidated Investee, Other
Schedule of Equity Method Investments [Line Items]
Total revenue	1,304
Total operating expenses	1,002
Operating income	302
Net income	123
Poseidon
Schedule of Equity Method Investments [Line Items]
Total revenue		147	132
Total operating expenses		36	35
Operating income		111	97
Net income		105	87
Balance Sheets
Current assets	18	31	30
Non-current assets	167	176	190
Total assets	185	207	220
Current liabilities	8	10	16
Non-current liabilities	232	238	246
Equity (Deficit)	(55)	(41)	(42)
Total liabilities and deficit	185	207	220
Poseidon | Equity Method Investment, Nonconsolidated Investee, Other
Schedule of Equity Method Investments [Line Items]
Total revenue	134
Total operating expenses	37
Operating income	97
Net income	93
Other
Schedule of Equity Method Investments [Line Items]
Total revenue		220	190
Total operating expenses		123	108
Operating income		97	82
Net income		88	73
Balance Sheets
Current assets	33	35	60
Non-current assets	871	920	917
Total assets	904	955	977
Current liabilities	43	56	73
Non-current liabilities	459	486	469
Equity (Deficit)	402	413	435
Total liabilities and deficit	904	955	977
Other | Equity Method Investment, Nonconsolidated Investee, Other
Schedule of Equity Method Investments [Line Items]
Total revenue	213
Total operating expenses	126
Operating income	87
Net income	$ 82
April 2020 Acquisition | Mattox
Schedule of Equity Method Investments [Line Items]
Total revenue		85
Total operating expenses		12
Operating income		$ 73
June 2019 Acquisition | Explorer
Schedule of Equity Method Investments [Line Items]
Total revenue			443
Total operating expenses			196
Operating income			247
June 2019 Acquisition | Colonial
Schedule of Equity Method Investments [Line Items]
Total revenue			1,437
Total operating expenses			735
Operating income			$ 702